Innovation is far more diffuse today, reflecting the increasingly fragmented nature of the pharma industry. On top of that, late-stage deals significantly underperform compared to early-stage strategy. So pharma may be in line for a shift in strategy. This edition of the “Inside Global Pharma” podcast features a discussion on an innovation constellation model, a focused and intentional strategy that emphasizes early-stage activity to drive long-term success.